The mutation N3481 in the connection domain of the HIV-1 reverse transcriptase is selected in vivo and confers decreased susceptibility to zidovudine and nevirapine

Thomas Hope (Editor), Soo Huey Yap, Brian Wynhoven, Ned Landau (Editor), Jennifer Anne Lewis, Michael Kuiper, Chih-Wei Sheen, Mark Zanin, Nicolas Sluis-Cremer, Richard Harrigan, Gilda Tachedjian

Research output: Contribution to conferenceAbstract

Original languageEnglish
Pages232 - 232
Number of pages1
Publication statusPublished - 2007
Event2007 Cold Spring Harbor Laboratory (CSHL) - Cold Spring Harbor NY USA, New York USA
Duration: 22 May 200727 May 2007


Conference2007 Cold Spring Harbor Laboratory (CSHL)
CityNew York USA

Cite this